Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 1,096 | 1,062 | 1,063 | 1,063 |
| Gross Profit | N/A | 1,096 | 1,062 | 1,063 | 1,063 |
| Operating Expenses | 6,159 | 6,682 | 6,543 | 6,525 | 6,988 |
| Operating Income | -6,159 | -5,586 | -5,481 | -5,462 | -5,925 |
| Other Income | 99 | 73 | 1,847 | 0 | 2 |
| Pre-tax Income | -6,060 | -5,513 | -3,634 | -5,462 | -5,923 |
| Net Income Continuous | -6,060 | -5,513 | -3,634 | -5,462 | -5,923 |
| Net Income | $-6,060 | $-5,513 | $-3,634 | $-5,462 | $-5,923 |
| EPS Basic Total Ops | -1.50 | -1.50 | -0.50 | -1.50 | -1.50 |
| EPS Basic Continuous Ops | -1.39 | -1.27 | -0.84 | -1.26 | -1.37 |
| EPS Diluted Total Ops | -1.50 | -1.50 | -0.50 | -1.50 | -1.50 |
| EPS Diluted Continuous Ops | -1.39 | -1.27 | -0.84 | -1.26 | -1.37 |
| EBITDA(a) | $-5,896 | $-5,313 | $-5,202 | $-5,184 | $-5,645 |